Edition:
United States

People: Abaxis Inc (ABAX.O)

ABAX.O on Nasdaq

48.08USD
24 Mar 2017
Change (% chg)

$-0.01 (-0.02%)
Prev Close
$48.09
Open
$48.19
Day's High
$48.82
Day's Low
$47.66
Volume
139,286
Avg. Vol
158,435
52-wk High
$55.95
52-wk Low
$41.58

Aron, Kenneth 

Dr. Kenneth P. Aron, Ph.D., is Chief Technology Officer of the Company. Dr. Aron joined us in February 2000 as Vice President of Research and Development. From April 1998 to November 1999, Dr. Aron was Vice President of Engineering and Technology of Incyte Pharmaceuticals (NASDAQ: INCY), a genomic information company. From April 1996 to April 1998, Dr. Aron was Vice President of Research, Development and Engineering for Cardiogenesis Corporation (NASDAQ: CGCP), a manufacturer of laser-based cardiology surgical products.

Basic Compensation

Total Annual Compensation, USD 702,058
Restricted Stock Awards, USD 1,817,640
Long-Term Incentive Plans, USD --
All Other, USD 26,895
Fiscal Year Total, USD 2,546,590

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Clinton Severson

4,361,190

Donald Wood

2,696,440

Ross Taylor

2,054,100

Kenneth Aron

2,546,590

Craig Tockman

2,541,620

Achim Henkel

2,044,750
As Of  30 Mar 2016